| pubmed-article:8664512 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8664512 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:8664512 | lifeskim:mentions | umls-concept:C0029216 | lld:lifeskim |
| pubmed-article:8664512 | lifeskim:mentions | umls-concept:C0002878 | lld:lifeskim |
| pubmed-article:8664512 | lifeskim:mentions | umls-concept:C2348930 | lld:lifeskim |
| pubmed-article:8664512 | lifeskim:mentions | umls-concept:C0003370 | lld:lifeskim |
| pubmed-article:8664512 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:8664512 | pubmed:dateCreated | 1996-8-6 | lld:pubmed |
| pubmed-article:8664512 | pubmed:abstractText | We report three instances of antibody-mediated hemolytic anemia following ABO-mismatched, but compatible, renal (n = 2) and simultaneous pancreas-kidney (n = 1) transplantation. The two renal allograft recipients had received a 6-antigen matched transplant; one received polyclonal antilymphocyte globulin to treat an early rejection episode. The simultaneous pancreas-kidney transplant received polyclonal antilymphocyte globulin (ALG) as part of a quadruple therapy induction regimen. All three patients developed severe, but self-limited, antibody-mediated hemolytic anemia within two weeks of their transplants. Serologic testing demonstrated the hemolysis to be antibody mediated; furthermore, testing of the ALG lots demonstrated high titers of anti-red blood cell antibodies. The possible contribution of ALG and HLA matching to the hemolysis seen in these patients after ABO mismatched organ transplantation is discussed. | lld:pubmed |
| pubmed-article:8664512 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8664512 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8664512 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8664512 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8664512 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8664512 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8664512 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8664512 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8664512 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:8664512 | pubmed:issn | 0902-0063 | lld:pubmed |
| pubmed-article:8664512 | pubmed:author | pubmed-author:DeChristopher... | lld:pubmed |
| pubmed-article:8664512 | pubmed:author | pubmed-author:PollakRR | lld:pubmed |
| pubmed-article:8664512 | pubmed:author | pubmed-author:RivasP APA | lld:pubmed |
| pubmed-article:8664512 | pubmed:author | pubmed-author:FabregaA JAJ | lld:pubmed |
| pubmed-article:8664512 | pubmed:author | pubmed-author:SoslerS DSD | lld:pubmed |
| pubmed-article:8664512 | pubmed:author | pubmed-author:VasquezE MEM | lld:pubmed |
| pubmed-article:8664512 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8664512 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:8664512 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8664512 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8664512 | pubmed:pagination | 166-9 | lld:pubmed |
| pubmed-article:8664512 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:8664512 | pubmed:meshHeading | pubmed-meshheading:8664512-... | lld:pubmed |
| pubmed-article:8664512 | pubmed:meshHeading | pubmed-meshheading:8664512-... | lld:pubmed |
| pubmed-article:8664512 | pubmed:meshHeading | pubmed-meshheading:8664512-... | lld:pubmed |
| pubmed-article:8664512 | pubmed:meshHeading | pubmed-meshheading:8664512-... | lld:pubmed |
| pubmed-article:8664512 | pubmed:meshHeading | pubmed-meshheading:8664512-... | lld:pubmed |
| pubmed-article:8664512 | pubmed:meshHeading | pubmed-meshheading:8664512-... | lld:pubmed |
| pubmed-article:8664512 | pubmed:meshHeading | pubmed-meshheading:8664512-... | lld:pubmed |
| pubmed-article:8664512 | pubmed:meshHeading | pubmed-meshheading:8664512-... | lld:pubmed |
| pubmed-article:8664512 | pubmed:meshHeading | pubmed-meshheading:8664512-... | lld:pubmed |
| pubmed-article:8664512 | pubmed:meshHeading | pubmed-meshheading:8664512-... | lld:pubmed |
| pubmed-article:8664512 | pubmed:meshHeading | pubmed-meshheading:8664512-... | lld:pubmed |
| pubmed-article:8664512 | pubmed:meshHeading | pubmed-meshheading:8664512-... | lld:pubmed |
| pubmed-article:8664512 | pubmed:meshHeading | pubmed-meshheading:8664512-... | lld:pubmed |
| pubmed-article:8664512 | pubmed:meshHeading | pubmed-meshheading:8664512-... | lld:pubmed |
| pubmed-article:8664512 | pubmed:meshHeading | pubmed-meshheading:8664512-... | lld:pubmed |
| pubmed-article:8664512 | pubmed:meshHeading | pubmed-meshheading:8664512-... | lld:pubmed |
| pubmed-article:8664512 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8664512 | pubmed:articleTitle | Antibody-mediated hemolytic anemia following ABO-mismatched organ transplantation: contributory role of HLA matching and polyclonal antilymphocyte globulin. | lld:pubmed |
| pubmed-article:8664512 | pubmed:affiliation | Department of Surgery/Division of Transplantation, University of Illinois, Chicago Medical Center, USA. | lld:pubmed |
| pubmed-article:8664512 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8664512 | pubmed:publicationType | Case Reports | lld:pubmed |
